ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1589

Obesity and Rehabilitation Outcomes After Lower Extremity Arthroplasty

Soham Al Snih, Amol Karmarkar, Timothy A. Reistetter, Jinhyung Lee, Amit Kumar, James E. Graham and Kenneth J. Ottenbacher, University of Texas Medical Branch, Galveston, TX

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: arthroplasty and obesity, OA

  • Tweet
  • Email
  • Print
Session Information

Title: Rehabilitation Sciences

Session Type: Abstract Submissions (ARHP)

Background/Purpose:

To examine the effect of obesity on inpatient rehabilitation outcomes after lower extremity arthroplasty procedures (hip and knee) among Medicare Beneficiaries aged 65 years and older.

Methods:

We conducted a retrospective analysis in a cohort of 103,445 Medicare Part A Beneficiaries with osteoarthritis who underwent primary total hip arthroplasty (THA) (N=32,671) or total knee arthroplasty (TKA) (N=70,774) between 2007 and 2009. Patients were identified using a combination of International Classification of Diseases, Ninth Revision and diagnosis related groups codes for primary THA or TKA, osteoarthritis, overweight/obesity, and morbid obesity. Data for rehabilitation outcomes were obtained using the Inpatient Rehabilitation Facilities Patient-Assessment Instrument file. Patients were grouped in three categories (normal weight, overweight/obesity, and morbid obesity). Rehabilitation outcomes included: Functional status information (FIM scores at admission and discharge, and FIM score change) and length of stay (LOS).  

Results:

The prevalence of overweight/obesity and morbid obesity was 11.4% vs. 4.7% among patients with THA, and 16.8% vs. 8.1% among patients with TKA. LOS was higher among morbid obesity for both THA and TKA [4.2, (Standard Deviation=2.7) vs. 4.2 (2.7)]. Mean FIM total score change was 29.4 (1.5) vs. 29.5 (12.3) for overweight/obesity and morbid obesity among those with THA, and 30.1 (11.5) vs. 31.3 (12.2) among those with TKA. Multivariable analysis for LOS controlled for age, gender, race/ethnicity, year of discharge, and discharge destination showed that LOS in morbid obesity in both THA and TKA was higher than those with normal weight or overweight/obesity (ß = 0.18, p-value 0.0037 vs. 0.20, p-value < 0.0001). Multivariable analysis for FIM total score change showed that the highest change was observed among morbid obesity with TKA (ß = 2.28, p-value < 0.0001) followed by morbid obesity with THA (ß = 0.91, p-value = 0.0018), overweight/obesity with TKA (ß = 0.89, p-value < 0.0001), and overweight/obesity with THA (ß = 0.43, p-value = 0.0236) when compared with normal weight.

Conclusion:

Patients with overweight/obesity and morbid obesity experience functional gains during inpatient rehabilitation, with those in the morbid obesity group experiencing the greatest gains. LOS for those with morbid obesity was greater than the other groups, providing support to the Center for Medicare and Medicaid Services tier comorbidity system for inpatient rehabilitation following THA or TKA. Our results suggest that obesity has an impact on LOS and functional status gains during rehabilitation. Future research is needed to explore the tier-based comorbidity reimbursement system and examine the impact of obesity on other rehabilitation impairment groups.


Disclosure:

S. Al Snih,
None;

A. Karmarkar,
None;

T. A. Reistetter,
None;

J. Lee,
None;

A. Kumar,
None;

J. E. Graham,
None;

K. J. Ottenbacher,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/obesity-and-rehabilitation-outcomes-after-lower-extremity-arthroplasty/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology